Literature DB >> 27143179

Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed.

Pieter J Hoekstra1, Jan K Buitelaar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27143179     DOI： 10.1007/s00787-016-0856-z

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  3 in total

1.  Why the Cochrane risk of bias tool should not include funding source as a standard item.

Authors:  Jonathan Ac Sterne
Journal:  Cochrane Database Syst Rev       Date:  2013-12-20

2.  Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?

Authors:  Pieter J Hoekstra; Jan K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-04       Impact factor: 4.785

Review 3.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.